Purpose: The prevalence and its impact on mortality of sepsis-induced cardiomyopathy (SICM) remain controversial. In this systematic review and meta-analysis, we investigated the prevalence and prognosis of SICM. Materials and Methods: We searched MEDLINE, Cochrane Central Register of Controlled Trials, and Embase. Titles and abstracts were evaluated based on the following criteria: (1) published in English, (2) randomized controlled trials, cohort studies, or cross-sectional studies, (3) ≥ 18 years with sepsis, (4) reporting the prevalence and/or comparison of short-term mortality between those with and without SICM, defined as the new-onset reduction in left ventricular ejection fraction (LVEF) within 72 h on admission or from the diagnosis of sepsis. The random-effect model was used for all analyses. This meta-analysis was registered at PROSPERO (CDR42022332896). Results: Sixteen studies reported the prevalence of SICM and the pooled prevalence of SICM was 20% (95% confidence interval [CI], 16-25%; I2 = 89.9%, P < 0.01). Eleven studies reported short-term mortality and SICM was associated with significantly higher short-term mortality (The pooled odds ratio: 2.30, 95% CI, 1.43-3.69; I2 = 0%, P = 0.001). Conclusion: The prevalence of SICM was 20% in patients with sepsis, and the occurrence of SICM was associated with significantly higher short-term mortality.
EvansLRhodesAAlhazzaniW, et al.Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med.2021;49(11):e1063-e1143.
2.
ParkerMMShelhamerJHBacharachSL, et al.Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med.1984;100(4):483-490.
3.
SatoRNasuM.A review of sepsis-induced cardiomyopathy. J Intensive Care.2015;3:48.
4.
HuangSJNalosMMcLeanAS.Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care.2013;17(3):R96.
5.
Sevilla BerriosRAO'HoroJCVelagapudiVPulidoJN. Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: A systematic review and meta-analysis. J Crit Care.2014;29(4):495-499.
6.
VerbruggeFHGuazziMTestaniJMBorlaugBA.Altered hemodynamics and End-organ damage in heart failure: Impact on the lung and kidney. Circulation.2020;142(10):998-1012.
7.
MoherDLiberatiATetzlaffJAltmanDGGroupP.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med.2009;151(4):264-269, W264.
8.
BoneRCBalkRACerraFB, et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest.1992;101(6):1644-1655.
9.
LevyMMFinkMPMarshallJC, et al.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med.2003;31(4):1250-1256.
10.
SingerMDeutschmanCSSeymourCW, et al.The third international consensus definitions for sepsis and septic shock (sepsis-3). Jama.2016;315(8):801-810.
11.
StangA.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol.2010;25(9):603-605.
12.
BarendregtJJDoiSALeeYYNormanREVosT.Meta-analysis of prevalence. J Epidemiol Community Health.2013;67(11):974-978.
13.
NyagaVNArbynMAertsM.Metaprop: A stata command to perform meta-analysis of binomial data. Arch Public Health.2014;72(1):39.
14.
HigginsJPThompsonSG.Quantifying heterogeneity in a meta-analysis. Stat Med.2002;21(11):1539-1558.
15.
MavridisDSalantiG.How to assess publication bias: Funnel plot, trim-and-fill method and selection models. Evid Based Ment Health.2014;17(1):30.
16.
DuvalSTweedieR.Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics.2000;56(2):455-463.
17.
Vieillard-BaronACailleVCharronCBelliardGPageBJardinF.Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med.2008;36(6):1701-1706.
18.
StoddardMFDillonSPetersGKupersmithJ.Left ventricular ejection fraction is increased during transesophageal echocardiography in patients with impaired ventricular function. Am Heart J.1992;123(4 Pt 1):1005-1010.
19.
PulidoJNAfessaBMasakiM, et al.Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc.2012;87(7):620-628.
20.
VallabhajosyulaSGillespieSMBarbaraDWAnavekarNSPulidoJN.Impact of new-onset left ventricular dysfunction on outcomes in mechanically ventilated patients with severe sepsis and septic shock. J Intensive Care Med.2018;33(12):680-686.
21.
ChenYZhangFYeX, et al.Association between gut dysbiosis and sepsis-induced myocardial dysfunction in patients with sepsis or septic shock. Front Cell Infect Microbiol.2022;12:857035.
22.
ChayakulWTongyooSPermpikulC.Incidence and outcomes of sepsis-related cardiomyopathy: A prospective cohort study. J Med Assoc Thai. 2021;104(3):497-505.
23.
HanumanthuBKJNairASKatamreddyA, et al.Sepsis-induced cardiomyopathy is associated with higher mortality rates in patients with sepsis. Acute Crit Care.2021;36(3):215-222.
24.
SongMJLeeSHLeemAY, et al.Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients. Acute Crit Care.2020;35(2):67-76.
25.
RazaziKBoissierFSurenaudM, et al.A multiplex analysis of sepsis mediators during human septic shock: A preliminary study on myocardial depression and organ failures. Ann Intensive Care.2019;9(1):64.
26.
JeongHSLeeTHBangCHKimJHHongSJ.Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: A comparative retrospective study. Medicine (Baltimore).2018;97(13):e0263.
27.
BoissierFRazaziKSeemannA, et al.Left ventricular systolic dysfunction during septic shock: The role of loading conditions. Intensive Care Med.2017;43(5):633-642.
28.
NarváezICanabalAMartínC, et al.Incidence and evolution of sepsis-induced cardiomyopathy in a cohort of patients with sepsis and septic shock. Med Intensiva (Engl Ed). 2018;42(5):283-291.
29.
WangBChenGLiJZengYWuYYanX.Neutrophil gelatinase-associated lipocalin predicts myocardial dysfunction and mortality in severe sepsis and septic shock. Int J Cardiol.2017;227:589-594.
30.
SatoRKuriyamaATakadaTNasuMLutheSK.Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study. Medicine (Baltimore).2016;95(39):e5031.
31.
DallaKHallmanCBech-HanssenOHaneyMRickstenSE.Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction. Cardiovasc Ultrasound.2015;13:30.
32.
RolandoGEspinozaEDAvidE, et al.Prognostic value of ventricular diastolic dysfunction in patients with severe sepsis and septic shock. Rev Bras Ter Intensiva. 2015;27(4):333-339.
33.
KloucheKPommetSAmiguesL, et al.Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: Relationships with systolic myocardial dysfunction and intensive care unit mortality. J Intensive Care Med.2014;29(4):229-237.
34.
PapanikolaouJMakrisDMpakaMPalliEZygoulisPZakynthinosE.New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care.2014;18(3):R94.
35.
ZhangZCDaiHWYuYHYangJDHuCB.Usefulness of heart-type fatty acid-binding protein in patients with severe sepsis. J Crit Care.2012;27(4):415.e413-418.
36.
LiangYWZhuYFZhangRZhangMYeXLWeiJR.Incidence, prognosis, and risk factors of sepsis-induced cardiomyopathy. World J Clin Cases.2021;9(31):9452-9468.
37.
MengJBHuMHZhangMHuGPZhangWHuSJ.The correlation between whole blood copper (cu), zinc (zn) levels and cu/zn ratio and sepsis-induced left ventricular systolic dysfunction (SILVSD) in patients with septic shock: A single-center prospective observational study. Int J Gen Med.2021;14:7219-7234.
38.
ChenXLiuXDongRZhangDQinS.A retrospective observational study of the association between plasma levels of interleukin 8 in 42 patients with sepsis-induced myocardial dysfunction at a single center between 2017 and 2020. Med Sci Monit.2021;27:e933065.
39.
ShinDGKangMKSeoYB, et al.Factors associated with abnormal left ventricular ejection fraction (decreased or increased) in patients with sepsis in the intensive care unit. PLoS One.2020;15(3):e0229563.
40.
WangHGaoYXWuYNLiCDuanJ.Association between plasma adiponectin levels and left ventricular systolic dysfunction in sepsis patients. J Crit Care.2020;60:195-201.
41.
BeesleySJWeberGSargeT, et al.Septic cardiomyopathy. Crit Care Med.2018;46(4):625-634.
42.
PernerAGordonACDe BackerD, et al. Sepsis: Frontiers in diagnosis, resuscitation and antibiotic therapy. Intensive Care Med.2016;42(12):1958-1969.
43.
FengMMcSparronJIKienDT, et al.Transthoracic echocardiography and mortality in sepsis: Analysis of the MIMIC-III database. Intensive Care Med.2018;44(6):884-892.
44.
DugarSSiubaMTSachaGL, et al.Echocardiographic profiles and hemodynamic response after vasopressin initiation in septic shock: A cross-sectional study. J Crit Care.2023;76:154298.
45.
WilkmanEKaukonenKMPettilaVKuitunenAVarpulaM.Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiol Scand.2013;57(4):431-442.
46.
SatoRAriyoshiNHasegawaD, et al.Effects of inotropes on the mortality in patients with septic shock. J Intensive Care Med.2021;36(2):211-219.
47.
LéopoldVGayatEPirracchioR, et al.Epinephrine and short-term survival in cardiogenic shock: An individual data meta-analysis of 2583 patients. Intensive Care Med.2018;44(6):847-856.
48.
LevyBClere-JehlRLegrasA, et al.Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol.2018;72(2):173-182.
49.
RankaSMastorisIKapurNK, et al.Right heart catheterization in cardiogenic shock is associated with improved outcomes: Insights from the nationwide readmissions database. J Am Heart Assoc.2021;10(17):e019843.
50.
VallabhajosyulaSShankarAPatlollaSH, et al.Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock. ESC Heart Fail.2020;7(3):1234-1245.
51.
SatoRHasegawaDDugarS.Do we have sufficient evidence to support the use of inotropes in patients with sepsis?Intensive Care Med.2022;48(2):253-254.
52.
Borges MigliavacaCSteinCColpaniVBarkerTHMunnZFalavignaM.How are systematic reviews of prevalence conducted? A methodological study. BMC Med Res Methodol.2020;20(1):96.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
